Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Oncology

• Publication date

  2006-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.29.1.209PMID 16773202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma.

  2004cited by this paper
• Antiangiogenic activity of aplidine, a new agent of marine origin

  2004cited by this paper
• Factor VII activating protease (FSAP) inhibits growth factor‐mediated cell proliferation and migration of vascular smooth muscle cells.

  2004cited by this paper
• Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis.

  2004cited by this paper
• Regulation of angiogenesis by hypoxia: role of the HIF system

  2003cited by this paper
• Anti-angiogenic Activity of the Recombinant Kringle Domain of Urokinase and Its Specific Entry into Endothelial Cells*

  2003cited by this paper
• Kringle structures and antiangiogenesis.

  2002cited by this paper
• Proteolytic activation and inactivation of the serine protease activity of plasma hyaluronan binding protein.

  2001cited by this paper
• Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.

  2001cited by this paper
• Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti‐angiogenesis in vivo

  2001cited by this paper
• Regulation mechanism of the serine protease activity of plasma hyaluronan binding protein.

  2001cited by this paper
• Identification of the substrates for plasma hyaluronan binding protein.

  2001cited by this paper
• Quantitation of the factor VII- and single-chain plasminogen activator-activating protease in plasmas of healthy subjects

  2001cited by this paper
• Generation of multiple angiogenesis inhibitors by human pancreatic cancer.

  2001cited by this paper
• HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.

  2000cited by this paper
• The FVII Activating Protease Cleaves Single-Chain Plasminogen Activators

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• A protease isolated from human plasma activating factor VII independent of tissue factor.

  1999cited by this paper
• Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

  1999cited by this paper
• Molecular mechanisms of blood vessel formation.

  1997cited by this paper
• Isolation and characterization of the plasma hyaluronan-binding protein (PHBP) gene (HABP2).

  1997cited by this paper
• Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

  1997cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Kringle Domains of Human Angiostatin

  1996cited by this paper
• Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator.

  1996cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane.

  1994cited by this paper

• Factor VII Activating Protease (FSAP) and Its Importance in Hemostasis—Part I: FSAP Structure, Synthesis and Activity Regulation: A Narrative Review

  2023cites this paper
• VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization

  2019influential citation
• The mechanisms of cellular signaling by Factor VII activating protease (FSAP)

  2018cites this paper
• Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model.

  2017cites this paper
• Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls.

  2017cites this paper
• Specific Extracellular Matrix Remodeling Signature of Colon Hepatic Metastases

  2013cites this paper
• The Factor VII-activating Protease (FSAP) Enhances the Activity of Bone Morphogenetic Protein-2 (BMP-2)*

  2013cites this paper
• In vivo and in vitro anti-angiogenesis effect of venom-derived peptides (ICD-85).

  2013cites this paper
• Hyaluronan-Binding Protease

  2013cites this paper
• Factor VII activating protease

  2011cites this paper
• Variation in Hyaluronan-Binding Protein 2 (HABP2) Promoter Region is Associated With Unexplained Female Infertility

  2011cites this paper
• Human endometrial receptivity and embryo-endometrium interactions

  2011cites this paper
• The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis

  2010cites this paper
• Proteomic analysis of proteins bound to adsorption units of extracorporeal liver support system under clinical conditions.

  2009cites this paper
• Factor VII-activating protease (FSAP): Vascular functions and role in atherosclerosis

  2008cites this paper